[Excerpt] The initial shortage of dextroamphetamine/amphetamine caused a subsequent increased demand for methylphenidate, which led to its own respective shortage in response.³ An additional reason for these shortages could be a lack of available active ingredients to manufacture the medications.⁴ This article will continue to discuss medications that are currently available as of January 2024 and may be used as treatment options to mitigate shortages and patient-related concerns (Table).^{6,9,10,14,16,17,19,20}